Table 1 Patient Characteristics and Treatments in Three Cohorts (n = 1,976)

Demographics:

Age

M = 63.8

M = 65.6

M = 60.7

<0.01

SD = 13.7

SD = 14.5

SD = 12.7

Gender (male)

510 (62.7%)

266 (58.9%)

443 (62.4%)

>0.36

Race (white)

682 (83.8%)

364 (80.5%)

606 (85.4%)

>0.09

Charlson Index

M = 2.32

M = 2.69

M = 2.09

<0.01

Med = 2

Med = 2

Med = 2

Range = 1–10

Range = 1–12

Range = 1–12

Ejection Fraction

<0.01

   <35%

83 (10.2%)

43 (9.5%)

75 (10.4%)

   35%–44%

121 (14.9%)

46 (10.2%)

115 (16.0%)

   ≥45%

396 (48.7%)

146 (32.3%)

422 (58.7%)

   missing

214 (26.3%)

217 (48.0%)

107 (14.9%)

No. of Vessels

<0.01

   0

28 (3.5)

14 (3.3)

66 (11.0)

   1

196 (24.6)

84 (20.0)

207 (34.3)

   2

180 (22.6)

80 (19.0)

155 (25.7)

   3

392 (49.2)

243 (57.7)

175 (29.0)

Invasive Procedures and Treatments:

None

200 (24.6)

142 (31.4)

72 (10.5)

<0.01

CATH

614 (75.4)

312 (68.4)

638 (89.5)

<0.01

PCI

216 (26.5)

136 (30.1)

342 (48.2)

<0.01

CABG

185 (22.7)

74 (16.4)

158 (22.3)

<0.01

Medications in Hospital:

ACEIs & ARBs

161 (19.8)

154 (34.7)

407 (57.3)

<0.01

Beta-Blockers

186 (24.1)

186 (41.2)

500 (70.4)

<0.01

Aspirin

498 (61.2)

307 (67.9)

614 (96.5)

<0.01

Thrombolytics

480 (59.0)

278 (61.5)

77 (10.9)

<0.01

Medications at Hospital Discharge:

ACEIs & ARBs

161 (19.8)

154 (34.7)

407 (57.3)

<0.01

Beta-Blockers

186 (24.1)

186 (41.2)

500 (70.4)

<0.01

Aspirin

498 (61.2)

307 (67.9)

614 (96.5)

<0.01